Literature DB >> 17435755

Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

Makiko Nagai1, Diane B Re, Tetsuya Nagata, Alcmène Chalazonitis, Thomas M Jessell, Hynek Wichterle, Serge Przedborski.   

Abstract

Mutations in superoxide dismutase-1 (SOD1) cause a form of the fatal paralytic disorder amyotrophic lateral sclerosis (ALS), presumably by a combination of cell-autonomous and non-cell-autonomous processes. Here, we show that expression of mutated human SOD1 in primary mouse spinal motor neurons does not provoke motor neuron degeneration. Conversely, rodent astrocytes expressing mutated SOD1 kill spinal primary and embryonic mouse stem cell-derived motor neurons. This is triggered by soluble toxic factor(s) through a Bax-dependent mechanism. However, mutant astrocytes do not cause the death of spinal GABAergic or dorsal root ganglion neurons or of embryonic stem cell-derived interneurons. In contrast to astrocytes, fibroblasts, microglia, cortical neurons and myocytes expressing mutated SOD1 do not cause overt neurotoxicity. These findings indicate that astrocytes may play a role in the specific degeneration of spinal motor neurons in ALS. Identification of the astrocyte-derived soluble factor(s) may have far-reaching implications for ALS from both a pathogenic and therapeutic standpoint.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435755      PMCID: PMC3799799          DOI: 10.1038/nn1876

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  38 in total

1.  Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.

Authors:  A M Clement; M D Nguyen; E A Roberts; M L Garcia; S Boillée; M Rule; A P McMahon; W Doucette; D Siwek; R J Ferrante; R H Brown; J-P Julien; L S B Goldstein; D W Cleveland
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

2.  Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70.

Authors:  Motoshi Sawada; Paulette Hayes; Shigemi Matsuyama
Journal:  Nat Cell Biol       Date:  2003-04       Impact factor: 28.824

3.  Directed differentiation of embryonic stem cells into motor neurons.

Authors:  Hynek Wichterle; Ivo Lieberam; Jeffery A Porter; Thomas M Jessell
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

4.  Functional network integration of embryonic stem cell-derived astrocytes in hippocampal slice cultures.

Authors:  Björn Scheffler; Tanja Schmandt; Wolfgang Schröder; Barbara Steinfarz; Leila Husseini; Jörg Wellmer; Gerald Seifert; Khalad Karram; Heinz Beck; Ingmar Blümcke; Otmar D Wiestler; Christian Steinhäuser; Oliver Brüstle
Journal:  Development       Date:  2003-11       Impact factor: 6.868

5.  Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.

Authors:  Y H Gong; A S Parsadanian; A Andreeva; W D Snider; J L Elliott
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

6.  Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease.

Authors:  M Nagai; M Aoki; I Miyoshi; M Kato; P Pasinelli; N Kasai; R H Brown; Y Itoyama
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

7.  Aging of chick embryo fibroblasts in vitro. III. Polyploid cell accumulation.

Authors:  K Kaji; M Matsuo
Journal:  Exp Cell Res       Date:  1979-03-15       Impact factor: 3.905

8.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

Authors:  David S Howland; Jian Liu; Yijin She; Beth Goad; Nicholas J Maragakis; Benjamin Kim; Jamie Erickson; John Kulik; Lisa DeVito; George Psaltis; Louis J DeGennaro; Don W Cleveland; Jeffrey D Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

9.  Functional properties of motoneurons derived from mouse embryonic stem cells.

Authors:  Gareth B Miles; Damien C Yohn; Hynek Wichterle; Thomas M Jessell; Victor F Rafuse; Robert M Brownstone
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

10.  Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

Authors:  Cédric Raoul; Alvaro G Estévez; Hiroshi Nishimune; Don W Cleveland; Odile deLapeyrière; Christopher E Henderson; Georg Haase; Brigitte Pettmann
Journal:  Neuron       Date:  2002-09-12       Impact factor: 17.173

View more
  519 in total

1.  Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity.

Authors:  Hiroki Shiwaku; Natsue Yoshimura; Takuya Tamura; Masaki Sone; Soichi Ogishima; Kei Watase; Kazuhiko Tagawa; Hitoshi Okazawa
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

Review 2.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

3.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 4.  Intercellular (mis)communication in neurodegenerative disease.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

5.  Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis.

Authors:  Pablo Díaz-Amarilla; Silvia Olivera-Bravo; Emiliano Trias; Andrea Cragnolini; Laura Martínez-Palma; Patricia Cassina; Joseph Beckman; Luis Barbeito
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-18       Impact factor: 11.205

Review 6.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 7.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

8.  Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS.

Authors:  Hong Z Yin; Darryl T Tang; John H Weiss
Journal:  Exp Neurol       Date:  2007-07-24       Impact factor: 5.330

9.  Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.

Authors:  Marcelo R Vargas; Delinda A Johnson; Daniel W Sirkis; Albee Messing; Jeffrey A Johnson
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

Review 10.  Stem cells in the nervous system.

Authors:  Angel R Maldonado-Soto; Derek H Oakley; Hynek Wichterle; Joel Stein; Fiona K Doetsch; Christopher E Henderson
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.